Skip to main content
SpringerLink
Log in

Comparison of the Anticancer Effect of Free and HPMA Copolymer-Bound Adriamycin in Human Ovarian Carcinoma Cells

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To study peculiarities and the mechanism of the anticancer effect of free and HPMA copolymer-bound ADR in sensitive and resistant human ovarian carcinoma cells.

Methods. Sensitive A2780 and ADR resistant A2780/AD cells were exposed to different doses of drugs during 12, 24, 36, 48, 60, and 72 hours. Cell viability, drug accumulation, apoptosis, cellular metabolism, lipid peroxidation, DNA content and gene expression were studied.

Results. HPMA copolymer-bound ADR (P(GFLG)-ADR) possessed a comparable cytotoxicity to free ADR when comparison was based on intracellular concentrations. While free ADR up-regulated genes encoding ATP driven efflux pumps (MDR1, MRP), P(GFLG)-ADR overcame existing pumps and down regulated the MRP gene. Free ADR also activated cell metabolism and expression of genes responsible for detoxification and DNA repair. P(GFLG)-ADR down-regulated HSP-70, GSr-π, BUDP, Topo-IIα, β, and TK-1 genes. Apoptosis, lipid peroxidation and DNA damage were significantly higher after exposure to P(GFLG)-ADR, as reflected by simultaneous activation of p53, c-fos in A2780 cells) or c-jun (A2780/AD) signaling pathways and inhibition of the bcl-2 gene. Differences between free ADR and P(GFLG)-ADR increased with the time of incubation and drug concentration.

Conclusions. P(GFLG)-ADR overcame drug efflux pumps, more significantly induced apoptosis and lipid peroxidation, inhibited DNA repair, replication, and biosynthesis when compared to free ADR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. M. Kool, M. de Haasde, G. L. Scheffer, R. J. Schapper, J. T. van Eijk, and J. A. Juijn. Analysis of expression of cMOAT (MRP2), MRP3, MRP4 and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57:3537–3547 (1997).

    Google Scholar 

  2. N. Krishnamachary and M. S. Center. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res. 53:3658–3661 (1993).

    Google Scholar 

  3. U. A. German. P-glycoprotein: a mediator of multidrug resistance in tumour cells. Eur. J. Cancer 32A:927–944 (1996).

    Google Scholar 

  4. D. A. Putman and J. Kopeček. Polymer conjugates with anticancer activity. Adv. Polym. Sci. 122:55–123 (1995).

    Google Scholar 

  5. V. Omelyanenko, C. Gentry, P. Kopečková, and J. Kopeček. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro. Int. J. Cancer 75:600–608 (1998).

    Google Scholar 

  6. H. J.-P. Ryser and W.-C. Shen. Conjugation of methotrexate to poly(L-lysine) increases drug transport and overcomes drug resistance in cultured cells. Proc. Natl. Acad,. Sci. U.S.A. 75:3867–3870 (1978).

    Google Scholar 

  7. M. Št'astný, J. Strohalm, D. Plocová, K. Ulbrich, and B. Říhová. Multidrug resistance (MDR) in cancer chemotherapy: possibility to overcome by HPMA-conjugated drugs. Abstract of 3rd International Symposium on Polymer Therapeutics, London, UK (1998).

  8. T. Minko, P. Kopečková, V. Pozharov, and J. Kopeček. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J. Contr. Rel. 54, 223–233 (1998).

    Google Scholar 

  9. T. Minko, P. Kopečková, and J. Kopeček. Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. J. Contr. Rel. (in press).

  10. K. Kunath, P. Kopečková, T. Minko, and J. Kopeček. HPMA copolymer—anticancer drugs—OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of same genes in the OVCAR-3 human ovarian carcinoma cell line. Eur. J. Pharm. Biopharm. (in press).

  11. J. Kopeček, P. Rejmanová, J. Strohalm, K. Ulbrich, B. Říhová, V. Chytrý, J. B. Lloyd, and R. Duncan. Synthetic polymeric drugs. U.S. Pat. 5,037,883 (Aug. 6, 1991).

  12. V. G. Omelyanenko, P. Kopečková, C. Gentry, J.-G. Shiah, and J. Kopeček. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. Influence of the methods of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro. J. Drug Target. 3:357–373 (1996).

    Google Scholar 

  13. P. Rejmanová, J. Labský, and J. Kopeček. Aminolyses of monomeric and polymeric p-nitrophenyl esters of methacryloylated amino acids. Makromol. Chem. 178:2159–2168 (1977).

    Google Scholar 

  14. E. C. Spoelstra, H. Dekker, G. J. Schuurhuis, H. J. Broxterman, and J.P. Lankelman. Glycoprotein drug efflux pump involved in the mechanism of intrinsic drug resistance in various colon cancer cell lines. Biochem. Pharmacol. 41:349–359 (1991).

    Google Scholar 

  15. M. B. Hansen, S. E. Nielsen, and K. Berg. Re-examination and further development of a precise and rapid dye method for measuring cell growing/cell kill. J. Immunol. Meth. 119:203–210 (1989).

    Google Scholar 

  16. F. Denizot and R. Lang. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Meth. 89:271–277 (1986).

    Google Scholar 

  17. K. E. Noonan, C. Beck, T. A. Holzmayer, J. E. Chin, J. S. Wunder, I. L. Andrulis, A. F. Gazdar, C. L. Willman, B. Griffith, D. D. Von Hoff, and I. B. Roninson. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. U.S.A. 87:7160–7164 (1990).

    Google Scholar 

  18. B. van Hille, A. Lohri, J. Reuter, and R. Rerrmann. Assessment of drug-induced dysregulations among seven resistance-associated genes in human tumor cell lines. Anticancer Res. 16:3531–3536 (1996).

    Google Scholar 

  19. C. M. Yuan, E. M. Bohen, F. Musio, and M. A. Carome. Sublethal heat shock and cyclosporine exposure produce tolerance against cyclosporine toxicity. Am. J. Physiol. 271:F571–F578 (1996).

    Google Scholar 

  20. J. E. Platt, X. He, D. Tang, J. Slater, and M. Goldstein. C-fos expression in vivo in human lymphocytes in response to stress. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 19:65–74 (1995).

    Google Scholar 

  21. J. Murray, V. Sheffield, J. L. Weber, G. Duyk, and K. H. Buetow. NSBI Entrez database, accession G15909, NID g1161798. (1995) (obtained through Internet: http://www.ncbi.nlm.nih.gov/Entrez/).

  22. K. Yagi. Lipid peroxides and human diseaases. Chem. Phys. Lipids 45:337–351 (1987).

    Google Scholar 

  23. J. L.-S. Au, N.P.D. Li, and Y. Gan. Apoptosis: a new pharmacodynamic endpoint. Pharm. Res. 14:1659–1671 (1997).

    Google Scholar 

  24. D. W. Loe, R. G. Decley, and S. P. C. Cole. Biology of the multidrug resistance associated protein, MRP. Eur. J. Cancer 32A:945–957 (1996).

    Google Scholar 

  25. K. D. Tew. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54:4313–4320 (1994).

    Google Scholar 

  26. A. Harris and D. Hochhauser. Mechanisms of multidrug resistance in cancer treatment. Acta Oncologica 2:205–213 (1992).

    Google Scholar 

  27. W.-J. Kim, Y. Kakehi, W.-J. Wu, M. Fukumoto, and O. Yoshida. Expression of multidrug resistance-related genes (mdr1, MRP, GST-π and DNA topoisomerase II) in urothelial cancers. Br. J. Urology 78:361–368 (1996).

    Google Scholar 

  28. C. Malhos, M. K. Howard, and D. S. Latchman. Heat shock protects neuronal cells from programmed cell death by apoptosis. Neuroscience 55:621–627 (1993).

    Google Scholar 

  29. T. R. Tritton. Cell surface actions of adriamycin. Pharm. Ther. 49:293–309 (1991).

    Google Scholar 

  30. B. K. Siesjö, K. I. Katsura, T. Kristián, P.-A. Li, and P. Siesjö. Molecular mechanisms of acidosis-mediated damage. Acta Neurochir. 66(Suppl): 8–14 (1996).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah

    Tamara Minko, Pavla Kopečková & Jindřich Kopeček

  2. Department of Bioengineering, University of Utah, Salt Lake City, Utah

    Pavla Kopečková & Jindřich Kopeček

Authors
  1. Tamara Minko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pavla Kopečková
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jindřich Kopeček
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jindřich Kopeček.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minko, T., Kopečková, P. & Kopeček, J. Comparison of the Anticancer Effect of Free and HPMA Copolymer-Bound Adriamycin in Human Ovarian Carcinoma Cells. Pharm Res 16, 986–996 (1999). https://doi.org/10.1023/A:1018959029186

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018959029186

Search

Navigation